Liquid biopsy can help to identify breast cancer patients with a poor prognosis earlier and more accurately than before, a new study from the University of Eastern Finland and Kuopio University Hospital shows. The findings were published in the peer-reviewed journal Cancers.
Liquid biopsy provides an alternative to traditional biopsy
The prognosis of breast cancer has continued to improve in Western countries. In Finland, for example, almost 90% of breast cancer patients are alive after five years of their breast cancer diagnosis. However, there are significant differences in the prognosis of different subtypes of breast cancer, and breast cancer eventually recurs in approximately 20–30% of patients.